Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,348
archived clinical trials in
Podiatry

Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated:  12/31/1969
mi
from
Tucson, AZ
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
SAVAHCS
mi
from
Tucson, AZ
Click here to add this to my saved trials
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated:  12/31/1969
mi
from
Dallas, TX
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)
Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) A Case Series of Initial Effectiveness and Safety Measures
Status: Enrolling
Updated: 12/31/1969
Richard C. Galperin, DPM
mi
from
Dallas, TX
Click here to add this to my saved trials
Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)
A Single Center Open Label Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail) of the Hallux Caused by Trichophyton Rubrum or Trichophyton Mentagrophytes.
Status: Enrolling
Updated:  12/31/1969
mi
from
Sacramento, CA
Early Feasibility Study to Evaluate the Efficacy of the RenewalNail™ Plasma Treatment System in Patients With Onychomycosis (Fungal Nail)
A Single Center Open Label Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail) of the Hallux Caused by Trichophyton Rubrum or Trichophyton Mentagrophytes.
Status: Enrolling
Updated: 12/31/1969
David L. Kahan, DPM
mi
from
Sacramento, CA
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Winter Haven, FL
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Bond Clinic / Clinical Reseach of Central Florida
mi
from
Winter Haven, FL
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Avon, IN
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
American Health Network
mi
from
Avon, IN
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
St. Anthony's Wound Care Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Mount Vernon, NY
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
A Step Ahead Foot Care
mi
from
Mount Vernon, NY
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Gramercy Park Podiatry
mi
from
New York, NY
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Foot Associates of New York
mi
from
New York, NY
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint George, UT
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Foot and Ankle Institute
mi
from
Saint George, UT
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Carlsbad, CA
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
ILD Research
mi
from
Carlsbad, CA
Click here to add this to my saved trials
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Overland Park, KA
MIRODERM H2H DFU Study
Effectiveness of MIRODERM® Biologic Wound Matrix in the Treatment of Hard-to-Heal Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Kansas City Institute of Podiatry
mi
from
Overland Park, KA
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Mesa, AZ
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
East Valley Foot & Ankle Specialists
mi
from
Mesa, AZ
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
San Francisco, CA
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Center for Clinical Research Inc.; i
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Durango, CO
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Animas Foot and Ankle
mi
from
Durango, CO
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Miami Lakes, FL
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
GF Professional Research Group Corporation
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Belleville, IL
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Podiatry 1st
mi
from
Belleville, IL
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Altoona, PA
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Clinical Research Associates of Central PA
mi
from
Altoona, PA
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
McAllen, TX
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Futuro Clinical Trials, LLC
mi
from
McAllen, TX
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
San Antonio, TX
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Endeavor Clinical Trials, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Suffolk, VA
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
1Foot 2Foot Centre for Foot & Ankle Care PC
mi
from
Suffolk, VA
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Aalborg,
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Aalborg Universitetshospital
mi
from
Aalborg,
Click here to add this to my saved trials
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
Wauwatosa, WI
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A in Participants With Neuropathic Non-Healing Diabetic Foot Ulcers
A Phase Ib, Blinded, Randomized, Multicenter, Multiple-Ascending−Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UTTR1147A Administered by Subcutaneous Injection in Patients With Non-Healing Neuropathic Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Steven M. Waldman, SC
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Study of Subjects With Diabetic Foot Ulcer (DFU)
Qualitative Research in Patients With Diabetic Foot Ulcer
Status: Enrolling
Updated:  12/31/1969
mi
from
Bethesda, MD
Study of Subjects With Diabetic Foot Ulcer (DFU)
Qualitative Research in Patients With Diabetic Foot Ulcer
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study Evaluating the Effect of Jublia on Dermatophytomas
An Investigator Initiated Pilot Study Evaluating the Efficacy of Efinaconazole 10% Solution (Jublia) for the Treatment of Onychomycosis With Dermatophytomas
Status: Enrolling
Updated:  12/31/1969
mi
from
Birmingham, AL
Study Evaluating the Effect of Jublia on Dermatophytomas
An Investigator Initiated Pilot Study Evaluating the Efficacy of Efinaconazole 10% Solution (Jublia) for the Treatment of Onychomycosis With Dermatophytomas
Status: Enrolling
Updated: 12/31/1969
Kirklin Clinic
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluation Of An Advanced Borderless Dressing
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated:  12/31/1969
mi
from
Phoenix, AZ
Evaluation Of An Advanced Borderless Dressing
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated: 12/31/1969
Titan Clinical Solutions
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation Of An Advanced Borderless Dressing
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated:  12/31/1969
mi
from
Shreveport, LA
Evaluation Of An Advanced Borderless Dressing
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated: 12/31/1969
Grace Research LLC
mi
from
Shreveport, LA
Click here to add this to my saved trials
Evaluation Of An Advanced Borderless Dressing
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated:  12/31/1969
mi
from
Summit, MO
Evaluation Of An Advanced Borderless Dressing
A Pilot Randomized Controlled Trial to Evaluate an Advanced Borderless Dressing
Status: Enrolling
Updated: 12/31/1969
Wound Care Plus, LLC
mi
from
Summit, MO
Click here to add this to my saved trials
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)
An Open-label, Multiple-dose Study Of The Absorption And Systemic Pharmacokinetics Of An2690 Applied As A 7.5% Solution To All Toenails Of Adult Patients With Moderate To Severe Onychomycosis
Status: Enrolling
Updated:  12/31/1969
mi
from
Bryan, TX
Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)
An Open-label, Multiple-dose Study Of The Absorption And Systemic Pharmacokinetics Of An2690 Applied As A 7.5% Solution To All Toenails Of Adult Patients With Moderate To Severe Onychomycosis
Status: Enrolling
Updated: 12/31/1969
J&S Studies
mi
from
Bryan, TX
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
Birmingham, AL
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant Site 01
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
Fountain Valley, CA
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant Site 38
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
Santa Rosa, CA
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant Site 15
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
South Miami, FL
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant SIte 05
mi
from
South Miami, FL
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
New Orleans, LA
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant Site 09
mi
from
New Orleans, LA
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
Baltimore, MD
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant Site 08
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
Forest Hills, NY
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant Site 02
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
Philadelphia, PA
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant Site 11
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
McAllen, TX
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant Site 07
mi
from
McAllen, TX
Click here to add this to my saved trials
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated:  12/31/1969
mi
from
Santo Domingo,
Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis
A Multicenter, Open Label, Single-arm Study Evaluating the Safety and Pharmacokinetics of Efinaconazole Topical Solution in Subjects With Mild to Severe Onychomycosis of the Toenails
Status: Enrolling
Updated: 12/31/1969
Valeant Site 10
mi
from
Santo Domingo,
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated:  12/31/1969
mi
from
Redwood City, CA
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Stanford Medical Center Hand and Upper Limb Center
mi
from
Redwood City, CA
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated:  12/31/1969
mi
from
San Francisco, CA
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
The Buncke Clinic
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated:  12/31/1969
mi
from
Portland, OR
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Veterans Affairs Medical Center - Portland
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated:  12/31/1969
mi
from
Danville, PA
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Geisinger Clinic
mi
from
Danville, PA
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated:  12/31/1969
mi
from
Philadelphia, PA
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated:  12/31/1969
mi
from
Philadelphia, PA
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
The Philadelphia Hand Center (affiliated to Thomas Jefferson Hospital)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated:  12/31/1969
mi
from
Richmond, VA
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
VCU Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated:  12/31/1969
mi
from
Paris,
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Clinique Chirurgicale Victor Hugo Paris
mi
from
Paris,
Click here to add this to my saved trials
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated:  12/31/1969
mi
from
Phoenix, AZ
Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Protect Neuro - Prospective Cohort Evaluation of NEUROCAP® In the Treatment of Symptomatic Neuroma
Status: Enrolling
Updated: 12/31/1969
Arizona Center for Hand Surgery
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail
An Open-Label Phase 2 Study to Investigate the Efficacy, Tolerability, and Safety of the HTS-519 Insert in the Treatment of Subjects With Distal Lateral Subungual Onychomycosis of the Great Toenail
Status: Enrolling
Updated:  12/31/1969
mi
from
Mesa, AZ
Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail
An Open-Label Phase 2 Study to Investigate the Efficacy, Tolerability, and Safety of the HTS-519 Insert in the Treatment of Subjects With Distal Lateral Subungual Onychomycosis of the Great Toenail
Status: Enrolling
Updated: 12/31/1969
Physician's Research Group
mi
from
Mesa, AZ
Click here to add this to my saved trials
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
A Prospective, Multicenter, Randomized, Single-Blind Clinical Investigation of Dermagraft(R) in Patients With Plantar Diabetic Foot Ulcers
Status: Enrolling
Updated:  12/31/1969
mi
from
San Antonio, TX
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
A Prospective, Multicenter, Randomized, Single-Blind Clinical Investigation of Dermagraft(R) in Patients With Plantar Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Richard Pollak, DPM
mi
from
San Antonio, TX
Click here to add this to my saved trials